{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:43:42Z","timestamp":1785545022105,"version":"3.56.0"},"reference-count":30,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n With a 5-year survival rate of less than 10% in most regions worldwide, pancreatic ductal adenocarcinoma (PDAC) has been considered as one of the deadliest tumor diseases. In addition, the incidence of acute and chronic pancreatitis is also increasing worldwide. Both diseases\u2014tumorous and inflammatory\u2014involve pronounced stromal changes, including stellate cell activation, fibrosis, immune cell recruitment, and a proinflammatory microenvironment that is able to drive malignant progression. Vitamin C is increasingly coming into focus as a treatment option, as it has the potential to act both as an antioxidant and anti-inflammatory agent on pancreatitis tissue and as a cytotoxic and modulatory agent on tumor-relevant signaling pathways in PDAC. While the influence of vitamin C on tumor cells has been extensively studied and classified, there is a lack of consideration in the context of stromal and epithelial cells in PDAC and benign\/inflammatory pancreatic diseases.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n This review aims to map the currently scattered literature and, thus, detect possible gaps in research. The research question posed for this purpose is as follows: what data are available on the influence of vitamin C on pancreatic stromal cells and pancreatic cells in benign\/inflammatory and malignant diseases of the pancreas?<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n The scoping review will be conducted using the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) guidelines and the recommendations of the Joanna Briggs Institute. The main systematic search will use PubMed, MEDLINE, and Web of Science, with gray literature identified via the Bielefeld Academic Search Engine. Two independent reviewers will then conduct title and abstract screening, followed by full-text screening. The main inclusion criteria are (1) pancreatic cells in malignant and inflammatory pancreatic diseases, (2) vitamin C intervention, and (3) effects studied at the cellular level. Relevant data will be extracted using a standardized Microsoft Excel spreadsheet. This information will include the title, author, year, study design, model, cell lines, vitamin C isoform, concentration, treatment duration, control, outcomes for pancreatic and stromal cells, methods, and key findings. This list may be expanded during screening. Data analysis will be descriptive, complemented by thematic grouping and visual representations. In accordance with the PRISMA-ScR recommendations, a formal risk-of-bias assessment will not be performed.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n As of April 13, 2026, a total of 475 database hits have been evaluated during the title and abstract screening process. The entire review process will extend from January 2026 to December 2026. Final results are expected in January 2027.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n This review aims to provide a comprehensive overview of the current state of knowledge in this field of research to structure it and, thus, highlight possible gaps in knowledge. This could serve as a basis for preclinical studies addressing specific gaps identified in this review to further elucidate the potential therapeutic role of vitamin C.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/91522","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T21:43:12Z","timestamp":1782164592000},"page":"e91522-e91522","source":"Crossref","is-referenced-by-count":0,"title":["The Influence of Vitamin C on Stromal and Epithelial Cells of the Pancreas in Malignant and Benign\/Inflammatory Pancreatic Diseases: Protocol for a Scoping Review"],"prefix":"10.2196","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3790-6992","authenticated-orcid":false,"given":"Hanna","family":"Plischke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1235-7512","authenticated-orcid":false,"given":"Yoshiaki","family":"Sunami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5267-079X","authenticated-orcid":false,"given":"Artur","family":"Rebelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3432-6669","authenticated-orcid":false,"given":"J\u00f6rg","family":"Kleeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"issue":"4","key":"R1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/JP9.0000000000000216","article-title":"Global characteristics of pancreatic cancer survival: a comprehensive overview of survival analysis from cancer registration data","volume":"8","author":"Chen","journal-title":"J Pancreatol"},{"issue":"6","key":"R2","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1097\/MPA.0000000000000588","article-title":"Recent trends in survival of patients with pancreatic cancer in Germany and the United States","volume":"45","author":"Sirri","journal-title":"Pancreas"},{"issue":"1","key":"R3","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-024-03481-8","article-title":"Global and regional burden of pancreatitis: epidemiological trends, risk factors, and projections to 2050 from the Global Burden of Disease Study 2021","volume":"24","author":"Li","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"R4","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/ueg2.12774","article-title":"Long-term mortality in acute pancreatitis-a population-based cohort study","volume":"13","author":"Selin","journal-title":"United European Gastroenterol J"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.612271","article-title":"Stroma involvement in pancreatic ductal adenocarcinoma: an overview focusing on extracellular matrix proteins","volume":"12","author":"Liot","journal-title":"Front Immunol"},{"issue":"9","key":"R6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17091541","article-title":"Stromal cells in early inflammation-related pancreatic carcinogenesis-biology and its potential role in therapeutic targeting","volume":"17","author":"Seidel","journal-title":"Cancers (Basel)"},{"issue":"1","key":"R7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/medicina56010015","article-title":"Tumor microenvironment","volume":"56","author":"Arneth","journal-title":"Medicina (Kaunas)"},{"issue":"11","key":"R8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14112608","article-title":"Repurposing vitamin C for cancer treatment: focus on targeting the tumor microenvironment","volume":"14","author":"Li","journal-title":"Cancers (Basel)"},{"issue":"1","key":"R9","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-018-0825-1","article-title":"Evaluation of the effects of ascorbic acid on metabolism of human mesenchymal stem cells","volume":"9","author":"Fujisawa","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"R10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3945\/an.110.000109","article-title":"Vitamin C: a concentration-function approach yields pharmacology and therapeutic discoveries","volume":"2","author":"Levine","journal-title":"Adv Nutr"},{"issue":"6","key":"R11","doi-asserted-by":"publisher","DOI":"10.3390\/ph15060711","article-title":"High-dose vitamin C for cancer therapy","volume":"15","author":"Mussa","journal-title":"Pharmaceuticals (Basel)"},{"issue":"9","key":"R12","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2174\/138920101609150715135921","article-title":"Treatment of pancreatic cancer with pharmacological ascorbate","volume":"16","author":"Cieslak","journal-title":"Curr Pharm Biotechnol"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7286737","article-title":"Pro- and antioxidant effects of vitamin C in cancer in correspondence to its dietary and pharmacological concentrations","volume":"2019","author":"Pawlowska","journal-title":"Oxid Med Cell Longev"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00015","article-title":"DNA damage, repair, and cancer metabolism","volume":"8","author":"Turgeon","journal-title":"Front Oncol"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2014.01.033","article-title":"Intracellular ascorbate enhances hypoxia-inducible factor (HIF)-hydroxylase activity and preferentially suppresses the HIF-1 transcriptional response","volume":"69","author":"Kuiper","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"R16","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1111\/cas.13990","article-title":"Hypoxia\/pseudohypoxia-mediated activation of hypoxia-inducible factor-1\u03b1 in cancer","volume":"110","author":"Hayashi","journal-title":"Cancer Sci"},{"issue":"2","key":"R17","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1158\/1078-0432.CCR-09-1713","article-title":"Mechanisms of ascorbate-induced cytotoxicity in pancreatic cancer","volume":"16","author":"Du","journal-title":"Clin Cancer Res"},{"issue":"10","key":"R18","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1055\/s-0035-1546132","article-title":"Mechanism of ascorbate-induced cell death in human pancreatic cancer cells: role of Bcl-2, Beclin 1 and autophagy","volume":"81","author":"Fukui","journal-title":"Planta Med"},{"issue":"1","key":"R19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-07668-1","article-title":"L-ascorbic acid preferentially kills KRAS mutant pancreatic cancer cells through DNA damage","volume":"15","author":"Jang","journal-title":"Sci Rep"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.734558","article-title":"The challenges and effects of ascorbic acid treatment of acute pancreatitis: a systematic review and meta-analysis of preclinical and clinical studies","volume":"8","author":"Gao","journal-title":"Front Nutr"},{"issue":"6","key":"R21","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.3349\/ymj.2007.48.6.1028","article-title":"Ascorbic acid alleviates pancreatic damage induced by dibutyltin dichloride (DBTC) in rats","volume":"48","author":"Lu","journal-title":"Yonsei Med J"},{"issue":"15","key":"R22","doi-asserted-by":"publisher","DOI":"10.3390\/nu17152390","article-title":"Targeting oxidative stress in acute pancreatitis: a critical review of antioxidant strategies","volume":"17","author":"Coman","journal-title":"Nutrients"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S415974","article-title":"High-dose vitamin C alleviates pancreatic necrosis by inhibiting platelet activation through the CXCL12\/CXCR4 pathway in severe acute pancreatitis","volume":"16","author":"Gui","journal-title":"J Inflamm Res"},{"issue":"6","key":"R24","doi-asserted-by":"publisher","first-page":"774","DOI":"10.3945\/an.115.009456","article-title":"Vitamins in pancreatic cancer: a review of underlying mechanisms and future applications","volume":"6","author":"Davis-Yadley","journal-title":"Adv Nutr"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.20517\/2394-4722.2021.02","article-title":"Novel approaches to therapeutics in pancreatic adenocarcinoma: vitamin C and tumor treatment fields","volume":"7","author":"Abushahin","journal-title":"J Cancer Metastasis Treat"},{"key":"R26","unstructured":"Forming answerable search questions using frameworks: PEO. University of Exeter Library. URL: https:\/\/libguides.exeter.ac.uk\/c.php?g=655921&p=5039312 [Accessed 25-11-2025]"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7647","article-title":"Preferred Reporting Items for Systematic review and Meta-Analysis Protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","journal-title":"BMJ"},{"issue":"7","key":"R28","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","journal-title":"Ann Intern Med"},{"issue":"1","key":"R29","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-020-01542-z","article-title":"PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews","volume":"10","author":"Rethlefsen","journal-title":"Syst Rev"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1002715","article-title":"A brief glimpse of a tangled web in a small world: tumor microenvironment","volume":"9","author":"Talaat","journal-title":"Front Med (Lausanne)"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e91522","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:24:08Z","timestamp":1785536648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e91522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":30,"URL":"https:\/\/doi.org\/10.2196\/91522","relation":{},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"article-number":"v15i4e91522"}}